Anna N. Tevyashova
- Molecular Biology
- Organic Chemistry top 10%
- Pharmacology top 10%
- Infectious Diseases top 10%
- Molecular Medicine top 10%
- Co-authors
- Eugenia N. OlsufyevaM. N. PreobrazhenskayaАlexander А. ShtilElena P. MirchinkElena B. IsakovaSvetlana E. SolovievaLyubov G. DezhenkovaAndrey E. Shchekotikhin
- Topics
- Cancer therapeutics and mechanisms (16 papers)Bioactive Compounds and Antitumor Agents (8 papers)Microbial Natural Products and Biosynthesis (8 papers)
- Partner nations
- RussiaUnited KingdomGermany
In The Last Decade
Anna N. Tevyashova
47 papers receiving 562 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 285
- Organic Chemistry 230
- Pharmacology 160
- Infectious Diseases 148
- Molecular Medicine 70
Countries citing papers authored by Anna N. Tevyashova
This map shows the geographic impact of Anna N. Tevyashova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna N. Tevyashova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna N. Tevyashova more than expected).
Fields of papers citing papers by Anna N. Tevyashova
This network shows the impact of papers produced by Anna N. Tevyashova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna N. Tevyashova. The network helps show where Anna N. Tevyashova may publish in the future.
Co-authorship network of co-authors of Anna N. Tevyashova
This figure shows the co-authorship network connecting the top 25 collaborators of Anna N. Tevyashova. A scholar is included among the top collaborators of Anna N. Tevyashova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna N. Tevyashova. Anna N. Tevyashova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 11 | |
| 8 | 2 | |
| 9 | 23 | |
| 10 | 7 | |
| 11 | 23 | |
| 12 | 24 | |
| 13 | 5 | |
| 14 | 4 | |
| 15 | 17 | |
| 16 | 15 | |
| 17 | Second Generation Drugs-derivatives of Natural Antitumor Anthracycline Antibiotics Daunorubicin, Doxorubicin and Carminomycin | 12 |
| 18 | 11 | |
| 19 | 6 | |
| 20 | 18 |
About Anna N. Tevyashova
Anna N. Tevyashova is a scholar working on Toxicology, Molecular Medicine and Pharmacology, having authored 50 papers that have together received 602 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Bioactive Compounds and Antitumor Agents (8 papers) and Microbial Natural Products and Biosynthesis (8 papers). The work is most often cited by research in Molecular Medicine (70 citations), Toxicology (34 citations) and Pharmacology (160 citations). Anna N. Tevyashova has collaborated with scholars based in Russia, United Kingdom and Germany. Frequent co-authors include Eugenia N. Olsufyeva, M. N. Preobrazhenskaya, Аlexander А. Shtil, Elena P. Mirchink, Elena B. Isakova, Svetlana E. Solovieva, Lyubov G. Dezhenkova, Andrey E. Shchekotikhin, Svetlana S. Efimova and Э. Р. Переверзева. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.